I am a 33-year-old woman looking for medical perspectives on changes to my menstrual cycle, hormone levels and ultrasound findings. I am particularly concerned about whether I have a hormonal imbalance, whether my uterine lining needs further investigation, and whether I should take the Provera recommended by my gynecologist.
Background and menstrual history
- Female, 33 years old.
- Had my first child at age 23.
- Before having children, my periods were very predictable, almost down to the day.
- After having children, my cycles became somewhat more irregular.
- Historically, my periods lasted approximately 4–5 days.
- Since November 2025, my periods have become increasingly shorter.
- More recently, I have approximately two days of menstrual flow, followed by pink or brown spotting that gradually tapers off.
- I also experience spotting before my period, sometimes beginning 5–7 days beforehand.
Hormone bloodwork
September 18, 2023
- Estradiol: 411 pmol/L
- LH: 1.1 IU/L
- Approximately cycle day 10.
Bleeding history:
- August 15–19, 2023.
- September 9–13, 2023.
- September 24–28, 2023.
March 27, 2025
- Estradiol: 508 pmol/L
- Progesterone: 0.8 nmol/L
- LH: 2.8 IU/L
- Cycle day 6.
- Previous period: March 22–24, 2025.
January 20, 2026
- Estradiol: 489 pmol/L
- Progesterone: 0.9 nmol/L
- LH: 3.0 IU/L
- Cycle day 5.
- Previous period: January 16–18, 2026.
February 26, 2026
- Estradiol: 379 pmol/L
- Progesterone: 51.1 nmol/L (flagged high by the laboratory).
- LH: 2.0 IU/L
- Cycle day 17.
- Previous period: February 10–13, 2026.
March 13, 2026
- Estradiol: 408 pmol/L
- Progesterone: 0.9 nmol/L
- LH: 5.4 IU/L
- Cycle day 4.
- Previous period: March 10–13, 2026.
October 2026
- Progesterone: 17.4 nmol/L.
- Tested as a day-21 progesterone.
- I experienced spotting and cramps the day before the blood test.
Laboratory reference ranges
Estradiol:
- Follicular: 77–921 pmol/L.
- Mid-cycle: 139–2382 pmol/L.
- Luteal: 77–1145 pmol/L.
- Post-menopausal: below 103 pmol/L.
Progesterone:
- Follicular: below 1.7 nmol/L.
- Luteal: 4.0–50.0 nmol/L.
- Post-menopausal: below 0.7 nmol/L.
LH:
- Follicular: 2.0–12.0 IU/L.
- Mid-cycle: 8.0–90.0 IU/L.
- Luteal: 1.0–14.0 IU/L.
My gynecologist previously told me that my estrogen was quite high and that my progesterone was too low to keep up with it.
Other bloodwork
March 27, 2024
Pelvic ultrasound findings
I have had several pelvic ultrasounds over the years. Since I started having ultrasounds, I have consistently had ovarian cysts or cyst-like findings that have appeared and subsequently resolved.
Findings from previous scans include:
Earlier ultrasound (Jan 21 2026)
- Endometrial thickness: 6 mm.
- Possible endometrial polyp measuring 4 mm.
- Right ovarian follicle/cyst measuring 2.1 cm.
Subsequent ultrasound (March 3 2026)
- Endometrial thickness: 6 mm.
- Previously described polyp was no longer visible.
- Left ovarian echogenic nodule measuring 1.7 cm.
- Possible explanations included dermoid, complex cyst or hematoma.
- Previously described right ovarian cyst had resolved.
Most recent ultrasound (June 1 2026)
- Endometrial thickness: 8 mm.
- A newly identified uterine fibroid.
- My period immediately preceding the scan was May 28–30, 2026, so the ultrasound was performed shortly after menstruation.
I am concerned about the change in lining thickness from 6 mm to 8 mm, particularly because the most recent scan was shortly after my period. I am also wondering whether the combination of a fibroid, a previously identified polyp and changes in my menstrual bleeding warrants further investigation.
Breast ultrasound findings and fibrocystic breasts
I have fibrocystic breasts, and my breast symptoms began approximately two years ago. I experience breast tenderness and discomfort that can fluctuate with my menstrual cycle.
My breast imaging has included:
March 28, 2025:
- Right breast, approximately 3 o'clock, retroareolar region: lobulated hypoechoic nodule measuring 9 × 8 × 5 mm.
- Left breast, approximately 12 o'clock: simple cyst measuring 3 mm.
Subsequent ultrasound (Oct 2026)
- Right breast finding measured approximately 6 × 6 × 4 mm.
- Described as having irregular margins.
- BI-RADS 3 assessment (probably benign).
- Left breast 3 mm simple cyst assessed as BI-RADS 2.
I am wondering whether these breast findings and fibrocystic changes could be related to hormonal fluctuations.
Gynecologist's recommendation and concerns about Provera
My gynecologist recommended Provera (medroxyprogesterone):
- Take it for 14 days each month.
- Continue until my bleeding pattern normalizes.
- Continue for a couple of additional months after that.
I understand that the intention may be to provide progesterone-like support to the uterine lining.
However, I am very anxious about taking it because I have read about potential cancer risks associated with hormonal medications.
At the same time, I am worried that if I don't take it, and I actually have insufficient progesterone exposure or prolonged estrogen exposure, I could increase my risk of endometrial hyperplasia or cancer.
I feel caught between worrying that taking Provera could cause cancer and worrying that not taking it could cause cancer.
My gynecologist recommended taking Provera for 14 days each month for a few months, explaining that it would help regulate my hormones and signal my brain to start producing progesterone naturally again. Is this how Provera works, or does it primarily protect the uterine lining and regulate bleeding while I'm taking it? I'm cautious about taking hormones long term and would like to understand whether a short course can help restore natural cycles, what the risks are, and how we would determine when it is appropriate to stop.
Family doctor's response and seeking a second opinion
I have raised these concerns with my family doctor, but she has been quite casual about the situation and has repeatedly reassured me that everything is fine.
I eventually had to actively request a referral to a gynecologist because I wanted a second opinion and a more thorough assessment. I am now seeking that second opinion.
I would particularly appreciate perspectives from gynecologists or physicians experienced in abnormal uterine bleeding in premenopausal women.
I am trying to understand whether this is more likely a benign hormonal or structural issue, whether I need additional testing, and how to make an informed decision about treatment.